Landry Kohou-koné*, Servais Saï, Joseph Kouadio Kouamé, Antoine Kouamé, Judith Bouh Sogbéti Diomandé, Sarah N’daw, Stéphane Adingra, Cédric Doh, Lossan Kra and Narcisse Boua

Covid 19 Intensive Care Unit, Infectious and Tropical Diseases Department, Treichville University Hospital, Abidjan (Ivory Coast), Felix Houphouēt Boigny University, Cocody, Abidjan Ivory Coast, West Africa

*Corresponding Author: Landry Kohou-Koné, Anesthesiology, Intensive and Emergency care Department, Felix Houphouēt Boigny University, Cocody, Abidjan Ivory Coast, West Africa.

Received: December 22, 2021; Published: January 20, 2022

Abstract

Background: To describe the epidemiological profile, risk factors and evolutionary aspects of patients who contracted acute renal dysfunction during their stay in a covid 19 critical care unit in Ivory Coast (West Africa).

Methods: Observational and cross-sectional study of four months (From May 1 to September 1, 2020) carried out in the intensive care unit of the infectious and tropical diseases department of Treichville University Hospital (Abidjan-Ivory Coast). All patients with a positive RT-PCR test were included. They were then categorized into two groups: the "AKI-CoV-2" group for patients who had developed acute renal failure (AKI); the "non-AKI-CoV-2" group concerning patients who didn’t developed acute renal failure during their stay in intensive care. The diagnosis and classification of AKI were based on the 2012 KDIGO recommendations.

Results: The prevalence of AKI was 26.5%. Regarding co-morbidities, there were no significant differences between the two groups apart from the arterial hypertension mainly found in the "AKI-CoV-2" group (p< 0.001). The majority of patients were at KDIGO 1 (58.97%) at the time of diagnosis. The average time to onset of acute renal failure was 3.2 days. There was a statistical difference between the two populations when compared for the need for mechanical ventilation, vasopressor amines and blood trasfusion requirement, with the AKI group requiring all this as opposed to the non-AKI group. Mortality was higher in the "AKI-CoV-2" group (81.6%, p < 0.001).

Conclusion: AKI complicating covid 19 is responsible for excess mortality with mechanical ventilation, the use of vasopressors and arterial hypertension as a risk factor.

Keywords: Covid 19; Acute Kidney Injury; Intensive Care; Ivory Coast

References

1. Christine Collienne., et al. “Prise en charge aux soins intensifs des patients pour insuffisance respiratoire liée au COVID-19”. Louvain Médical 139 (2020): 383-389.
2. Paul Gabarre., et al. “Acute kidney injury in patient with severe SARS- CoV-2 infection”. Medecine Intensive Réanimation 30 (2021): 43-52.
3. Jamie S Hirsch., et al. “Acute kidney injury in patients hospitalized with COVID-19 injury”. Kidney International 98 (2020): 209-218.
4. The ICNARC COVID-19 Team., et al. “COVID-19 in critical care: epidemiology of the first epidemic wave across England, Wales and Northem Ireland”. Intensive Care Medicine 46 (2020): 2035-2047.
5. Dawei Wang., et al. “Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected/Pneumonia in Wuhan, China”. JAMA 323 (2020): 1061-1069.
6. Ling Hu., et al. “Risk factors associated with clinical outcomes in 323 covid-19 hospitalized patients in Wuhan, China”. Clinical Infectious Diseases 71 (2020) : 2089-2098.
7. Sébastien Rubin., et al. “Characterization of acute kidney in critically ill patients with severe coronavirus disease 2019”. Clinical Kidney Journal 13 (2020): 354-361.
8. Adrien Joseph., et al. “Acute kidney injury in patients with SARS-CoV-2 infection”. Annals of Intensive Care 10 (2020): 117.
9. Rhama Karray., et al. “Surmortalité de l’insuffisance rénale oligoanurique au cours de la COVI-19 : étude prospective tunisienne”. Néphrologie and Thérapeutique 16 (2020): 312.
10. Alexandra Beurton., et al. “Limiting positive end-expiratory pressure to protect renal function in SARS-CoV-2 critically ill patients”. Journal of Critical Care 59 (2020): 191-193.
11. Masataka Nishiga., et al. “COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives”. Nature Reviews Cardiology 17 (2020): 543-558.
12. Yichun Cheng., et al. “Kidney disease is associated with in-hospital death of patients with covid-19”. Kidney International 97 (2020): 829-838.
13. Ruchong Chen., et al. “Risk factors or fatal outcome in hospitalized subjects with doronavirus Disease 2019 from a national analysis in China”. Chest 158 (2020): 97-105.
14. Lili Chan., et al. “AKI in hospitalizaed patients with covid-19”. Journal of the American Society of Nephrology 32 (2021): 151-160.
15. Shruti Gupta., et al. “AKI treated with renal replacement therapy in critically ill patients covid-19”. Journal of the American Society of Nephrology 32 (2021): 161-176.
16. Jun Jie Ng., et al. “Acute kidney injury in hospitalized patients with coronavirus disease 2019 (COVID-19): A meta-analysis”. Journal of Infection 81 (2020): 647-679.

Citation

Citation: Landry Kohou-koné., et al. “Acute Kidney Injury in Patients With Covid 19 in Ivory Coast (West Africa) Intensive Care Unit”.Acta Scientific Medical Sciences 6.2 (2022): 127-131.

Copyright

Copyright: © 2022 Landry Kohou-koné., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.